Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10209 | 1081 | 39.6 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
1843 | 2 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO | 6139 |
10209 | 1 | ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3 | 1081 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARSENIC TRIOXIDE | authKW | 7574052 | 47% | 53% | 505 |
2 | AS2O3 | authKW | 371005 | 3% | 39% | 34 |
3 | ARSENIC TRIOXIDE AS2O3 | authKW | 244422 | 1% | 58% | 15 |
4 | TETRAARSENIC OXIDE | authKW | 145262 | 1% | 86% | 6 |
5 | ACUTE PROMYELOCYTIC LEUKEMIA | authKW | 116905 | 6% | 7% | 63 |
6 | ARSENIC DISULFIDE | authKW | 90385 | 0% | 80% | 4 |
7 | DARINAPARSIN | authKW | 90385 | 0% | 80% | 4 |
8 | ORGANIC ARSENICALS | authKW | 90385 | 0% | 80% | 4 |
9 | KML001 | authKW | 84737 | 0% | 100% | 3 |
10 | THIACETARSAMIDE SODIUM | authKW | 84737 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6399 | 40% | 0% | 435 |
2 | Hematology | 3426 | 18% | 0% | 191 |
3 | Toxicology | 706 | 8% | 0% | 90 |
4 | Pharmacology & Pharmacy | 425 | 14% | 0% | 150 |
5 | Cell Biology | 175 | 9% | 0% | 92 |
6 | Medicine, Research & Experimental | 143 | 5% | 0% | 59 |
7 | Biochemistry & Molecular Biology | 103 | 13% | 0% | 138 |
8 | Integrative & Complementary Medicine | 83 | 1% | 0% | 13 |
9 | Biophysics | 29 | 3% | 0% | 33 |
10 | Gastroenterology & Hepatology | 14 | 2% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENVIRONM CHEMODYNAM | 67783 | 1% | 40% | 6 |
2 | MOL CELL BIOL FUNCT GENOM | 63551 | 0% | 75% | 3 |
3 | SHANGHAI HEMATOL | 43497 | 2% | 7% | 22 |
4 | HEMATOL NEOPLASMS | 37660 | 0% | 67% | 2 |
5 | THER EUT HEMATOL TRADIT CHINESE MED | 37660 | 0% | 67% | 2 |
6 | CLIN MOL GENET | 32901 | 1% | 8% | 15 |
7 | ACUTE CARE NURSE PRACTITIONER PROGRAM ONCOL SUBSP | 28246 | 0% | 100% | 1 |
8 | ADRI BERNIE BANTON | 28246 | 0% | 100% | 1 |
9 | ADULT ONCOLKRAFT FAMILY BLOOD DONOR | 28246 | 0% | 100% | 1 |
10 | BAYI POSTDOCTORAL WORKSTN | 28246 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOLOGY REPORTS | 2037 | 2% | 0% | 27 |
2 | LEUKEMIA & LYMPHOMA | 1932 | 2% | 0% | 23 |
3 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1816 | 2% | 0% | 25 |
4 | MOLECULAR CANCER THERAPEUTICS | 1538 | 1% | 0% | 15 |
5 | LEUKEMIA RESEARCH | 1486 | 2% | 0% | 18 |
6 | LEUKEMIA | 1183 | 2% | 0% | 18 |
7 | BLOOD | 1131 | 4% | 0% | 38 |
8 | MEDICAL ONCOLOGY | 1023 | 1% | 0% | 11 |
9 | ONCOLOGIST | 1019 | 1% | 0% | 9 |
10 | BRITISH JOURNAL OF HAEMATOLOGY | 890 | 2% | 0% | 21 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARSENIC TRIOXIDE | 7574052 | 47% | 53% | 505 | Search ARSENIC+TRIOXIDE | Search ARSENIC+TRIOXIDE |
2 | AS2O3 | 371005 | 3% | 39% | 34 | Search AS2O3 | Search AS2O3 |
3 | ARSENIC TRIOXIDE AS2O3 | 244422 | 1% | 58% | 15 | Search ARSENIC+TRIOXIDE+AS2O3 | Search ARSENIC+TRIOXIDE+AS2O3 |
4 | TETRAARSENIC OXIDE | 145262 | 1% | 86% | 6 | Search TETRAARSENIC+OXIDE | Search TETRAARSENIC+OXIDE |
5 | ACUTE PROMYELOCYTIC LEUKEMIA | 116905 | 6% | 7% | 63 | Search ACUTE+PROMYELOCYTIC+LEUKEMIA | Search ACUTE+PROMYELOCYTIC+LEUKEMIA |
6 | ARSENIC DISULFIDE | 90385 | 0% | 80% | 4 | Search ARSENIC+DISULFIDE | Search ARSENIC+DISULFIDE |
7 | DARINAPARSIN | 90385 | 0% | 80% | 4 | Search DARINAPARSIN | Search DARINAPARSIN |
8 | ORGANIC ARSENICALS | 90385 | 0% | 80% | 4 | Search ORGANIC+ARSENICALS | Search ORGANIC+ARSENICALS |
9 | KML001 | 84737 | 0% | 100% | 3 | Search KML001 | Search KML001 |
10 | THIACETARSAMIDE SODIUM | 84737 | 0% | 100% | 3 | Search THIACETARSAMIDE+SODIUM | Search THIACETARSAMIDE+SODIUM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DILDA, PJ , HOGG, PJ , (2007) ARSENICAL-BASED CANCER DRUGS.CANCER TREATMENT REVIEWS. VOL. 33. ISSUE 6. P. 542-564 | 111 | 62% | 168 |
2 | ROJEWSKI, MT , KORPER, S , SCHREZENMEIER, H , (2004) ARSENIC TRIOXIDE THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA AND BEYOND: FROM BENCH TO BEDSIDE.LEUKEMIA & LYMPHOMA. VOL. 45. ISSUE 12. P. 2387 -2401 | 96 | 62% | 33 |
3 | GAZITT, Y , AKAY, C , (2005) ARSENIC TRIOXIDE: AN ANTI CANCER MISSILE WITH MULTIPLE WARHEADS.HEMATOLOGY. VOL. 10. ISSUE 3. P. 205-213 | 77 | 65% | 34 |
4 | LITZOW, MR , (2008) ARSENIC TRIOXIDE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 9. ISSUE 10. P. 1773-1785 | 58 | 64% | 30 |
5 | HOFFMAN, E , MIELICKI, WP , (2013) ARSENIC TRIOXIDE: IMPACT ON THE GROWTH AND DIFFERENTIATION OF CANCER CELLS AND POSSIBLE USE IN CANCER THERAPY.POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. VOL. 67. ISSUE . P. 817-827 | 52 | 64% | 5 |
6 | GAO, YH , ZHANG, HP , YANG, SM , YANG, Y , MA, YY , ZHANG, XY , YANG, YM , (2014) INACTIVATION OF AKT BY ARSENIC TRIOXIDE INDUCES CELL DEATH VIA MITOCHONDRIAL-MEDIATED APOPTOTIC SIGNALING IN SGC-7901 HUMAN GASTRIC CANCER CELLS.ONCOLOGY REPORTS. VOL. 31. ISSUE 4. P. 1645 -1652 | 44 | 65% | 2 |
7 | CHEN, D , CHAN, R , WAXMAN, S , JING, YK , (2006) BUTHIONINE SULFOXIMINE ENHANCEMENT OF ARSENIC TRIOXIDE-INDUCED APOPTOSIS IN LEUKEMIA AND LYMPHOMA CELLS IS MEDIATED VIA ACTIVATION OF C-JUN NH2-TERMINAL KINASE AND UP-REGULATION OF DEATH RECEPTORS.CANCER RESEARCH. VOL. 66. ISSUE 23. P. 11416-11423 | 35 | 90% | 42 |
8 | EVENS, AM , TALLMAN, MS , GARTENHAUS, RB , (2004) THE POTENTIAL OF ARSENIC TRIOXIDE IN THE TREATMENT OF MALIGNANT DISEASE: PAST, PRESENT, AND FUTURE.LEUKEMIA RESEARCH. VOL. 28. ISSUE 9. P. 891-900 | 57 | 50% | 111 |
9 | HU, J , FANG, J , DONG, Y , CHEN, SJ , CHEN, Z , (2005) ARSENIC IN CANCER THERAPY.ANTI-CANCER DRUGS. VOL. 16. ISSUE 2. P. 119-127 | 40 | 73% | 40 |
10 | EMADI, A , GORE, SD , (2010) ARSENIC TRIOXIDE - AN OLD DRUG REDISCOVERED.BLOOD REVIEWS. VOL. 24. ISSUE 4-5. P. 191 -199 | 39 | 54% | 98 |
Classes with closest relation at Level 1 |